Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. (julio de 2004). «SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation». Journal of Immunology173 (2): 945-54. PMID15240681. doi:10.4049/jimmunol.173.2.945.
Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. (Abril de 2008). «B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells». Blood111 (7): 3635-43. PMID18223165. doi:10.1182/blood-2007-11-123141.
Clark CA, Gupta HB, Sareddy G, Pandeswara S, Lao S, Yuan B, Drerup JM, Padron A, Conejo-Garcia J, Murthy K, Liu Y, Turk MJ, Thedieck K, Hurez V, Li R, Vadlamudi R, Curiel TJ. (Diciembre de 2016). «Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.». Cancer Research76 (23): 6964-74. PMID27671674. doi:10.1158/0008-5472.CAN-16-0258.
Gato-Cañas M, Zuazo M, Arasanz H, Ibañez-Vea M, Lorenzo L, Fernandez-Hinojal G, Vera R, Smerdou C, Martisova E, Arozarena I, Wellbrock C, Llopiz D, Ruiz M, Sarobe P, Breckpot K, Kochan G, Escors D. (Agosto de 2017). «PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity». Cell Reports20 (8): 1818-29. PMID28834746. doi:10.1016/j.celrep.2017.07.075.
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. (agosto de 2002). «Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion». Nature Medicine8 (8): 793-800. PMID12091876. doi:10.1038/nm730.
Lin DY1, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. (Diciembre de 2007). «The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors». PNAS105 (8): 3011-3016. PMID18287011. doi:10.1073/pnas.0712278105.
Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, Qiu Y, Jussif JM, Carter LL, Wood CR, Chaudhary D. (septiembre de 2004). «PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta». FEBS Letters574 (1-3): 37-41. PMID15358536. doi:10.1016/j.febslet.2004.07.083.
Flies DB, Chen L (abril de 2007). «The new B7s: playing a pivotal role in tumor immunity». Journal of Immunotherapy30 (3): 251-60. PMID17414316. doi:10.1097/CJI.0b013e31802e085a.
Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H (noviembre de 2002). «Expression of programmed death 1 ligands by murine T cells and APC». Journal of Immunology169 (10): 5538-45. PMID12421930. doi:10.4049/jimmunol.169.10.5538.
Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI, Park YM, Oh S, Shin JG, Yao S, Chen L, Choi IH (febrero de 2006). «Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274)». FEBS Letters580 (3): 755-62. PMID16413538. doi:10.1016/j.febslet.2005.12.093.
Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. (julio de 2004). «SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation». Journal of Immunology173 (2): 945-54. PMID15240681. doi:10.4049/jimmunol.173.2.945.
Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. (Abril de 2008). «B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells». Blood111 (7): 3635-43. PMID18223165. doi:10.1182/blood-2007-11-123141.
Clark CA, Gupta HB, Sareddy G, Pandeswara S, Lao S, Yuan B, Drerup JM, Padron A, Conejo-Garcia J, Murthy K, Liu Y, Turk MJ, Thedieck K, Hurez V, Li R, Vadlamudi R, Curiel TJ. (Diciembre de 2016). «Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.». Cancer Research76 (23): 6964-74. PMID27671674. doi:10.1158/0008-5472.CAN-16-0258.
Gato-Cañas M, Zuazo M, Arasanz H, Ibañez-Vea M, Lorenzo L, Fernandez-Hinojal G, Vera R, Smerdou C, Martisova E, Arozarena I, Wellbrock C, Llopiz D, Ruiz M, Sarobe P, Breckpot K, Kochan G, Escors D. (Agosto de 2017). «PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity». Cell Reports20 (8): 1818-29. PMID28834746. doi:10.1016/j.celrep.2017.07.075.
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. (agosto de 2002). «Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion». Nature Medicine8 (8): 793-800. PMID12091876. doi:10.1038/nm730.
Lin DY1, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. (Diciembre de 2007). «The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors». PNAS105 (8): 3011-3016. PMID18287011. doi:10.1073/pnas.0712278105.
Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, Qiu Y, Jussif JM, Carter LL, Wood CR, Chaudhary D. (septiembre de 2004). «PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta». FEBS Letters574 (1-3): 37-41. PMID15358536. doi:10.1016/j.febslet.2004.07.083.
Flies DB, Chen L (abril de 2007). «The new B7s: playing a pivotal role in tumor immunity». Journal of Immunotherapy30 (3): 251-60. PMID17414316. doi:10.1097/CJI.0b013e31802e085a.
Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H (noviembre de 2002). «Expression of programmed death 1 ligands by murine T cells and APC». Journal of Immunology169 (10): 5538-45. PMID12421930. doi:10.4049/jimmunol.169.10.5538.
Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI, Park YM, Oh S, Shin JG, Yao S, Chen L, Choi IH (febrero de 2006). «Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274)». FEBS Letters580 (3): 755-62. PMID16413538. doi:10.1016/j.febslet.2005.12.093.